Loading…
Underlying
Underlying Price
$39.57
Type
Put
Strike
42
Expiration
Feb 19, 2027
DTE
135d
Moneyness
ITM
Intrinsic
$2.43
EWTX 42 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $2.47 | -26.27% | 2 | 43 |
| Nov 20, 2026 | 44d | $5.00 | +51.52% | 2 | 10 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | $5.40 | +0.00% | 1 | 1 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $10.30 | +0.00% | 47 | 47 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.